IPDsim: An interpretable model to assess individual clinical antagonism in combination therapies for cancers. Model performance across development and validation cohorts.
Lung cancer (LC) is a leading cause of cancer-related mortality in the United States. Accurate prediction of LC mortality rates is crucial for guiding targeted interventions and addressing health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results